News

Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
ONE of Belfast’s longest standing investment management firms Cunningham Coates is rebranding to Smith & Williamson, the ...
Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.
NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...
After BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...
This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...
Lack of mRNA funding could pose a national security risk; CureVac, GSK settle mRNA suit against Pfizer, BioNTech; Gilead confident in HIV prevention drug prospects.
Are women somehow missing from the future of innovation? New research suggests that gender bias may be quietly shaping the ...
“Stratus,” originally known as Variant XFG, is the second most prominent strain of COVID in the United States. According to ...